Used primarily in research as a structural analog of nicotine, this compound serves as an intermediate in the development of nicotinic acetylcholine receptor (nAChR) modulators. It is investigated for potential applications in neurological disorders, including Alzheimer's and Parkinson's diseases, due to its ability to interact with central nervous system receptors. Additionally, it has been explored in the design of novel compounds for smoking cessation therapies. Its structural features make it valuable in medicinal chemistry for optimizing binding affinity and selectivity toward specific receptor subtypes.